Hjem › KOLS › Michigan › Dearborn
Kliniske studier for KOLS i Dearborn, MI
4 studier for KOLS søker deltakere på steder i og rundt Dearborn (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
RekruttererFase 3
- Vitalis Clinical Research Center- Site Number : 8400040, Allen Park · 5 mi unna
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
RekruttererFase 2/3
- Revival Research Institute, LLC, Dearborn
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
RekruttererFase 3
- GSK Investigational Site, Dearborn
- GSK Investigational Site, Allen Park · 5 mi unna
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
RekruttererFase 3
- GSK Investigational Site, Allen Park · 5 mi unna
KOLS-studier i andre byer
- Philadelphia, PA23 studier
- Miami, FL18 studier
- Birmingham, AL17 studier
- Boston, MA17 studier
- Houston, TX15 studier
- Orlando, FL15 studier
- Baltimore, MD14 studier
- Chicago, IL14 studier
- Dallas, TX12 studier
- Pittsburgh, PA12 studier
- New York City, NY11 studier
- Ann Arbor, MI10 studier
Andre studier i Dearborn
- Ikke-småcellet lungekreft6 studier
- Lungekreft6 studier
- Prostatakreft6 studier
- Brystkreft6 studier
- Kolorektal kreft4 studier
- Nyrekreft (nyrecellekarcinom)4 studier
- Blærekreft4 studier
- Type 2-diabetes3 studier
- Eggstokkreft3 studier
- Pankreaskreft3 studier
Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.